1. Home
  2. PGNY vs HTGC Comparison

PGNY vs HTGC Comparison

Compare PGNY & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Progyny Inc.

PGNY

Progyny Inc.

HOLD

Current Price

$27.45

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Hercules Capital Inc.

HTGC

Hercules Capital Inc.

N/A

Current Price

$17.40

Market Cap

2.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PGNY
HTGC
Founded
2008
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
PGNY
HTGC
Price
$27.45
$17.40
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$26.50
$18.86
AVG Volume (30 Days)
995.3K
1.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
12.13%
EPS Growth
14.04
14.91
EPS
0.63
0.90
Revenue
$1,288,661,000.00
N/A
Revenue This Year
$8.87
$11.18
Revenue Next Year
$9.76
$5.24
P/E Ratio
$42.90
$19.48
Revenue Growth
10.40
N/A
52 Week Low
$16.10
$13.70
52 Week High
$33.07
$19.62

Technical Indicators

Market Signals
Indicator
PGNY
HTGC
Relative Strength Index (RSI) 51.50 55.37
Support Level $25.16 $15.17
Resistance Level $27.56 $19.05
Average True Range (ATR) 0.78 0.28
MACD 0.29 -0.04
Stochastic Oscillator 82.28 42.95

Price Performance

Historical Comparison
PGNY
HTGC

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.

Share on Social Networks: